Lipoxin A4 regulates bronchial epithelial cell responses to acid injury

American Journal of Pathology

Volumn 168, Issue 4, 2006, Pages 1064-1072

  Bonnans, Caroline ^a   Fukunaga, Koichi ^a   Levy, Marilyn A ^a,b   Levy, Bruce D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; CYCLOOXYGENASE 2; HYDROCHLORIC ACID; INTERLEUKIN 6; LIPOXIN A; PROSTAGLANDIN E2; RECEPTOR;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPIRATION; BRONCHUS INJURY; BRONCHUS MUCOSA; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESPIRATORY FAILURE; RESPIRATORY TRACT INFLAMMATION; STOMACH ACID; TRANSMISSION ELECTRON MICROSCOPY;

EID: 33645459968     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051056     Document Type: Article

References (40)

1. Nathan C: Points of control in inflammation. Nature 2002, 420:846-852
2. Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP: Lipid mediator-induced expression of bactericidal/permeability- increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci USA 2002, 99:3902-3907
3. Wynne JW, Ramphal R, Hood CI: Tracheal mucosal damage after aspiration. A scanning electron microscope study. Am Rev Respir Dis 1981, 124:728-732
4. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349
5. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987, 237:1171-1176
6. 2. Nat Immunol 2000, 1:42-46
7. Matthay MA, Zimmerman GA: Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005, 33:319-327
8. Gilroy DW, Lawrence T, Perretti M, Rossi AG: Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004, 3:401-416
9. Serhan CN: Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005, 73:141-162
10. McMahon B, Godson C: Lipoxins: endogenous regulators of inflammation. Am J Physiol 2004, 286:F189-F201
11. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 1997, 185:1693-1704
12. Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD: Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 2005, 174:5033-5039
13. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol 2000, 164:1029-1036
14. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999, 5:698-701
15. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN: Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001, 2:612-619
16. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408
17. Parkos CA, Delp C, Arnaout MA, Madara JL: Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction. J Clin Invest 1991, 88:1605-1612
18. Savla U, Appel HJ, Sporn PH, Waters CM: Prostaglandin E(2) regulates wound closure in airway epithelium. Am J Physiol 2001, 280:L421-L431
19. Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, Collins PD, Kay AB: Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology 1992, 77:330-337
20. Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP: Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005, 33:1-6; discussion 230-232
21. 4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J Clin Invest 1993, 92:75-82
22. 2 in mediating acid-aspiration injury. Surgery 1992, 111:55-61
23. 4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J Exp Med 1998, 187:1285-1294
24. 2+ increase in human bronchial epithelium. J Biol Chem 2003, 278:10879-10884
25. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989, 320:365-376
26. Bonner JC, Rice AB, Ingram JL, Moomaw CR, Nyska A, Bradbury A, Sessoms AR, Chulada PC, Morgan DL, Zeldin DC, Langenbach R: Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am J Pathol 2002, 161:459-470
27. Davies NM, Sharkey KA, Asfaha S, Macnaughton WK, Wallace JL: Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 1997, 11:1101-1108
28. Maricic N, Ehrlich K, Gretzer B, Schuligoi R, Respondek M, Peskar BM: Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach. Br J Pharmacol 1999, 128:1659-1666
29. Gretzer B, Maricic N, Respondek M, Schuligoi R, Peskar BM: Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 2001, 132:1565-1573
30. Souza MH, de Lima Jr OM, Zamuner SR, Fiorucci S, Wallace JL: Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. Am J Physiol 2003, 285:G54-G61
31. 4 analogs. J Clin Invest 1998, 101:1860-1869
32. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol 2002, 168:5260-5267
33. 4'S anti-inflammatory actions on intestinal epithelium. Am J Physiol 2003, 284:C888-C896
34. Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman M: A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 2005, 280:15267-15278
35. Claria J, Lee MH, Serhan CN: Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med 1996, 2:583-596
36. 4 inhibits proliferation of human lung fibroblasts induced by CTGF. Am J Respir Cell Mol Biol 2006, 34:65-72
37. 4 modifies platelet-derived growth factor-induced profibrotic gene expression in human renal mesangial cells. Am J Pathol 2005, 167:683-694
38. 4 receptor interaction. Biochemistry 1995, 34:16678-16686
39. Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN: Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am J Pathol 2001, 158:3-9
40. Kieran NE, Doran PP, Connolly SB, Greenan MC, Higgins DF, Leonard M, Godson C, Taylor CT, Henger A, Kretzler M, Burne MJ, Rabb H, Brady HR: Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int 2003, 64:480-492